Abstract
MHC peptides derived from tumor-associated antigens (TAAs) can serve as the basis for the development of immunotherapeutics to treat human malignancies. Previously, we identified novel HLA-A*0201 (HLA-A2)-restricted peptides recovered from soluble HLA molecules secreted by human tumor cell lines, transfected with truncated genes of HLA-A2 and HLA-B7. Here, 4 candidate peptides eluted from soluble HLA-A2 were selected on the basis of their precursor proteins being TAAs. Peptide p1028 (GLIEKNIEL), derived from DNA methyltransferase I (DNMT-1), which is overexpressed in various human tumors, showed the highest affinity to HLA-A2 and was relatively abundant in the sMHC/peptide complexes of all transfected breast, ovarian and prostate cancer cell lines. Peptide p1028-specific CTLs were generated in vitro and shown to efficiently lyse not only target cells pulsed with the peptide but also HLA-A2-positive breast cancer cell lines MDA-231 and MCF-7. The peptide induced IFN-gamma production in CTLs, which were selectively stained by a p1028 tetramer. Since DNMT-1 is a widely expressed tumor-associated enzyme, the novel DNMT-1-derived, HLA-A2-restricted peptide GLIEKNIEL identified here may provide a suitable candidate for a therapeutic ...Continue Reading
References
Nov 1, 1992·The Journal of Experimental Medicine·C TraversariT Boon
Mar 6, 1992·Science·D F HuntV H Engelhard
Apr 15, 1991·Proceedings of the National Academy of Sciences of the United States of America·W S el-DeiryS B Baylin
Apr 25, 1970·Nature·J J van RoodM C van Santen
Nov 6, 1970·Science·R K Charlton, C M Zmijewski
Apr 19, 1984·Nature·H G Rammensee, M J Bevan
Apr 29, 1994·Science·A L CoxC L Slingluff
Nov 1, 1993·Proceedings of the National Academy of Sciences of the United States of America·R A HendersonV H Engelhard
Mar 1, 1994·European Journal of Immunology·G StuberG Klein
May 5, 1994·Nature·O MandelboimL Eisenbach
Aug 1, 1993·The Journal of Experimental Medicine·V BrichardT Boon
Jan 1, 1993·Annual Review of Immunology·H G RammenseeO Rötzschke
Mar 4, 1997·Proceedings of the National Academy of Sciences of the United States of America·Y T ChenL J Old
Nov 22, 1997·Current Opinion in Immunology·A Moretta, L Moretta
Feb 17, 1998·European Journal of Immunology·H JonuleitA H Enk
Sep 22, 1998·The Journal of Experimental Medicine·R LupettiC Traversari
May 15, 1999·Nucleic Acids Research·K D RobertsonP A Jones
Dec 22, 1999·Immunogenetics·H RammenseeS Stevanović
May 8, 2000·International Journal of Cancer. Journal International Du Cancer·E JägerA Knuth
Oct 12, 2000·Proceedings of the National Academy of Sciences of the United States of America·E JägerA Knuth
Jan 10, 2002·European Journal of Immunology·Eilon BarneaArie Admon
Nov 7, 2002·Annals of Oncology : Official Journal of the European Society for Medical Oncology·J Goffin, E Eisenhauer
Dec 24, 2002·Nature Genetics·Marie-France RobertA Robert MacLeod
Citations
Mar 20, 2012·Molecular Immunology·Katherine E ScullAnthony W Purcell
Apr 4, 2015·Immunology Letters·Daphna LazarusGideon Gross
May 5, 2017·DNA and Cell Biology·Anning YangYideng Jiang
Mar 19, 2008·Journal of Proteome Research·Oriana E HawkinsWilliam H Hildebrand